11/17
2021

Treatment of Severe Alcohol Withdrawal Syndrome

2:00 pm - 3:00 pm
Off Campus
Neil Wallis, PharmD, MBA, BCPS
Click link to MetroWest Medical Center registration

Treatment of Severe Alcohol Withdrawal Syndrome

Schedule:        November 17, 2021, 2 to 3pm, Framingham, MA

Audience:        Accredited for Pharmacists and Technicians

                         Other interested health care professionals welcome

Credits:           1 Contact Hour knowledge based

                         0.1CEU will be awarded under the provider       

Presenters:      Neil Wallis, PharmD, MBA, BCPS, Clinical Pharmacy Manager-- Antimicrobial Stewardship CoChair, Framingham, MA 01704

Registration:    No registration fees

 

Pharmacists Learning Objectives: 0837-9999-21-232-L01-P

After attending this program, participants will be able to:

  1. Identify the pharmacologic targets of benzodiazepines and barbiturates for the treatment of alcohol withdrawal syndrome (AWS)
  2. Review the pharmacokinetic and pharmacodynamics of benzodiazepines
  3. Recognize the efficacy of various treatment strategies for the management of severe AWS

Technicians Learning Objectives- 0837-9999-21-233-L01-T

  1. Identify the medications used in severe alcohol withdrawal syndrome (AWS)
  2. Review the storage requirements for medication used in AWS
  3. Distinguish what CIWA score correlates to mild, moderate and severe withdrawal

Requirements for Receiving CE Credit:

  • Successful completion of post-presentation questions
  • Participation at live program
  • Complete program evaluation form